Nabriva, Roivant Collaborate For China Rights To Novel Antibiotic
You May Interested In
2026-07-27
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Titan Technology Makes Bold Move with 55.85 Million Yuan Acquisition of UK Biochemical Firm ASL — What's Behind the Deal?
-
Kering and L'Oréal Form $4 Billion Strategic Alliance in Luxury Beauty and Wellness
-
Wanhua Chemical's Hungarian 650,000-ton MDI/TDI Plant to Shut Down for 35-Day Maintenance
-
Beiersdorf Delivers 2025 Growth Despite Ongoing Market Pressure
-
Yulong Petrochemical’s 100,000-ton MMA Project Comes Online Amid a “Deep V-Shaped Rebound” — Opportunity or Hidden Risk?
-
BASF Battles Market Turmoil as Profits Slide
-
Cadmium Sulfide Uses: Pigments, Semiconductors & Safety Tips
-
Symrise Launches “Care & Wellness” Division to Strengthen Beauty–Health Integration
-
IMCD to Acquire 100% of Italian Coatings Distributor Tillmanns
-
China National Salt Industry Corporation Advances 10,000 t/y Sodium Metal Expansion Project, Industry Leader Invests Nearly RMB 100 Million
Recommend Reading
-
Univar Solutions Expands Partnership with American Distilling in EMEA to Strengthen Natural Specialty Ingredients Distribution Network
-
Saint-Gobain’s Triple Acquisition: The “Small but Sophisticated” Strategy Behind Low-Carbon Building Materials
-
Pfizer Warns Germany: Drug Pricing Could Put Investment at Risk
-
J&J VAT Dispute Threatens Free Medicine Access in Britain
-
Lier Chemical Gains Momentum as Chlorantraniliprole Supply Stabilizes
-
Weak Decline in TDI Market in September
-
FDA Dye Tracker Raises Reformulation Pressure Across Food Brands
-
Rigid Demand Supports Acrylic Acid, Short-Term Moving Average Shows Rising Signal
-
In September, the caustic soda price in China showed a generally weak trend
-
This week, the Chinese epichlorohydrin market continues to maintain a stable operation trend (6.15-6.18)